Literature DB >> 10395945

Enhancement of tyrosyl phosphorylation and protein expression of eps8 by v-Src.

M C Maa1, J R Lai, R W Lin, T H Leu.   

Abstract

Two eps8 isoforms, p97eps8 and p68eps8, were previously identified as substrates for receptor tyrosine kinases. Analysis of eps8 phosphotyrosine content in v-Src transformed cells (IV5) revealed that both isoforms were highly tyrosyl phosphorylated and their readiness to be phosphorylated by Src in vitro further indicated that they were putative Src substrates as well. Indeed, the enhancement of tyrosyl phosphorylation of p97eps8 detected in cells coexpressing both p97eps8 and active Src relative to that in cells expressing p97eps8 alone supported our hypothesis. The existence of common phosphotryptic peptides between in vitro 32P-labeled p97eps8 and p68eps8 indicated that these two proteins shared the same Src-mediated sites. Further in vitro binding assays demonstrated that p68eps8 was the major eps8 isoforms that could be precipitated by bacterial fusion protein containing Src SH3. Interestingly, both p68eps8 and p97eps8 were preferentially expressed in v-Src transformed cells and the presence of p68eps8 appeared to depend on Src. Since p97eps8 has been implicated in mitogenesis and tumorigenesis, its readiness to be phosphorylated and induced by v-Src might attribute to v-Src-mediated transformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395945     DOI: 10.1016/s0167-4889(99)00069-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Eps8 protein facilitates phagocytosis by increasing TLR4-MyD88 protein interaction in lipopolysaccharide-stimulated macrophages.

Authors:  Yen-Jen Chen; Ming-Yu Hsieh; Miao Ying Chang; Hui-Chen Chen; Ming-Shiou Jan; Ming-Chei Maa; Tzeng-Horng Leu
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

2.  The inducible nitric-oxide synthase (iNOS)/Src axis mediates Toll-like receptor 3 tyrosine 759 phosphorylation and enhances its signal transduction, leading to interferon-β synthesis in macrophages.

Authors:  Ming-Yu Hsieh; Miao Ying Chang; Yen-Jen Chen; Yung Kuo Li; Tsung-Hsien Chuang; Guann-Yi Yu; Chun Hei Antonio Cheung; Hui-Chen Chen; Ming-Chei Maa; Tzeng-Horng Leu
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

3.  Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.

Authors:  Debbie L Cunningham; Steve M M Sweet; Helen J Cooper; John K Heath
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

4.  A RhoA and Rnd3 cycle regulates actin reassembly during membrane blebbing.

Authors:  Kana Aoki; Fumiyo Maeda; Tomoya Nagasako; Yuki Mochizuki; Seiichi Uchida; Junichi Ikenouchi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

5.  Novel binding partners and differentially regulated phosphorylation sites clarify Eps8 as a multi-functional adaptor.

Authors:  Debbie L Cunningham; Andrew J Creese; Giulio Auciello; Steve M M Sweet; Tulin Tatar; Joshua Z Rappoport; Melissa M Grant; John K Heath
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  Eps8 controls Src- and FAK-dependent phenotypes in squamous carcinoma cells.

Authors:  Christina Schoenherr; Bryan Serrels; Charlotte Proby; Debbie L Cunningham; Jane E Findlay; George S Baillie; John K Heath; Margaret C Frame
Journal:  J Cell Sci       Date:  2014-10-29       Impact factor: 5.285

7.  EPS8 phosphorylation by Src modulates its oncogenic functions.

Authors:  Linah A Shahoumi; Hesam Khodadadi; Husam Bensreti; Babak Baban; W Andrew Yeudall
Journal:  Br J Cancer       Date:  2020-07-09       Impact factor: 7.640

8.  Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours (Review).

Authors:  Kaili Luo; Lei Zhang; Yuan Liao; Hongyu Zhou; Hongying Yang; Min Luo; Chen Qing
Journal:  Oncol Rep       Date:  2021-01-07       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.